TORONTO, ONTARIO--(Marketwired - Feb 23, 2017) - Spectral Medical Inc., ("Spectral" or the "Company"), (EDT.TO) a Phase III company developing the first treatment for patients with endotoxemic septic ...
Chembio Diagnostics, Inc. reports that it has filed the second module of its Pre-Marketing Approval (PMA) application to the United States Food & Drug Administration for its DPP® HIV 1/2 Assay which ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback